HRSA Tells Federal Court it Still Stands by its 340B Patient Definition in Closely Watched Case

Genesis
HRSA says it stands by its patient definition in Genesis' federal lawsuit seeking a far broader definition.
The U.S. Health Resources and Services Administration (HRSA) still stands by its 340B program patient definition, the agency said in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Johnson & Johnson, Astellas Each Sue to Stop Medicare Drug Price Negotiations

Johnson & Johnson and Astellas
Johnson & Johnson and Astellas are the latest drugmakers to sue in federal court to stop Medicare drug price negotiation.
Drug manufacturers Johnson & Johnson and Astellas Pharma have each asked federal district courts to strike down parts of the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Judge Rejects 340B Provider Challenge to California Medicaid Drug Payment Shift

U.S. District Court Sacramento
A federal district judge in Sacramento, Calif., dismissed a lawsuit on July 17 aimed at reversing the state’s transfer of Medicaid managed care drugs benefits to Medicaid fee for service.
A federal district judge in Sacramento, Calif., recently dismissed a lawsuit aimed at reversing the state’s January 2022 transfer of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

U.S. Chamber of Commerce Asks Court to Pause Medicare Drug Price Negotiations

U.S. Chamber of Commerce
The U.S. Chamber of Commerce asked a federal district court last week for a preliminary injunction against Medicare drug price negotiation.
The U.S. Chamber of Commerce asked a federal district court in Ohio last week to stop Medicare from implementing the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Prime Vendor Apexus and AIDS Healthcare Foundation Are Trying to Settle Lawsuit Over Sub-Ceiling Price Discounts

AIDS Healthcare Foundation and Apexus
AHF has asked a federal appeals court to reverse an earlier court's decision to dismiss a case against Apexus over its provision of 340B sub-ceiling price discounts on drugs.
Apexus, the federally contracted 340B prime vendor, and AIDS Healthcare Foundation are meeting with a mediator to try to settle [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Health Center Invokes 340B Contract Pharmacy Ruling in Key 340B Patient Definition Federal Lawsuit

Genesis Health Care
South Carolina health center Genesis Health Care told a federal court that HRSA lacks authority to enforce its 1996 340B patient definition and misinterpreted congressional intent about who is a 340B eligible patient.

Federal health care officials can’t make a South Carolina health center obey their reading of the 340B patient definition for the same reason a federal appeals court said in January that the officials can’t force drug manufacturers to deliver 340B

Read More »

PhRMA and Bristol Myers Squibb Sue Separately To Stop Medicare Drug Price Negotiation

US District Court Austin, Texas
PhRMA filed suit in federal district court in Austin, Texas, to strike down legislation letting Medicare negotiate some drug prices.

Drug industry trade group Pharmaceutical Research and Manufacturers of America and drug manufacturer Bristol Myers Squibb have filed separate federal lawsuits to stop Medicare from negotiating the prices of some drugs, charging that it would impose unconstitutional price controls on

Read More »

First Merck, Now Chamber of Commerce Sues to Stop Medicare Drug Price Negotiation

U.S. Chamber of Commerce
The U.S. Chamber of Commerce and local and state chambers have sued to stop Medicare from negotiating "maximum fair prices" on a small number of expensive single-source drugs.

The U.S. Chamber of Commerce and three state and local affiliates are asking a federal court to strike down the part of the Inflation Reduction Act that lets Medicare negotiate “maximum fair prices” (MFPs) for some expensive, single-source drugs, arguing

Read More »

Federal Court Hearing Next Week on California’s Medicaid Drug Benefit Transfer; Bill Introduced in N.J. with 340B Implications

U.S. District Court Sacramento
A federal district judge in Sacramento, Calif., is holding arguments next week in a lawsuit to reverse the state’s transfer of Medicaid managed care benefits to Medicaid fee for service.

A federal district judge in Sacramento, Calif., is holding oral arguments next week in a lawsuit aimed at reversing the state’s January 2022 transfer of Medicaid managed care benefits to Medicaid fee for service.

Meanwhile, a bill was introduced

Read More »

Merck Sues to Stop Medicare Drug Price Negotiation

Merck
Merck has sued to stop the federal government from negotiating prices for certain high expenditure, single source Medicare Part B or Part D drugs

Federal Medicare drug price negotiation “is tantamount to extortion” and must be struck down as unconstitutional, drug manufacturer Merck told a federal district court yesterday.

Merck on Tuesday became the first drug maker to sue to stop the federal government

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live